Literature DB >> 3806119

Four cases of late onset metachromatic leucodystrophy in a family: clinical, biochemical and neuropathological studies.

D Alves, M M Pires, A Guimarães, M C Miranda.   

Abstract

Four cases of familial metachromatic leucodystrophy are described: the age of onset ranged from 15 to 21 years. Mental deterioration was the earliest clinical sign to be noted and all progressed to severe dementia. The arylsulphatase activity in peripheral leucocytes of the patients was very low, 5 to 15 nmol/h/mg protein, moderately reduced in the heterozygote, 40 nmol/h/mg protein, compared with control values of 60-160 nmol/h/mg protein. Sural nerve biopsies in two cases showed perivascular macrophages filled with metachromatic material and electron microscopy showed typical inclusions in Schwann cell cytoplasm. Necropsy in one of the cases revealed severe demyelination mainly in the cerebral hemispheres with metachromatic material in macrophages and neurons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3806119      PMCID: PMC1029128          DOI: 10.1136/jnnp.49.12.1417

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  THE RECTAL APPROACH TO NEUROPATHOLOGY.

Authors:  M BODIAN; B D LAKE
Journal:  Br J Surg       Date:  1963-07       Impact factor: 6.939

2.  Juvenile metachromatic leukodystrophy: deficiency of an arylsufatase A component.

Authors:  Y Suzuki; Y Mizuno
Journal:  J Pediatr       Date:  1974-12       Impact factor: 4.406

3.  [Metachromatic leucodystrophy in a young adult; clinical, biological and ultrastructural study].

Authors:  S Brion; J Mikol; J Graveleau
Journal:  Rev Neurol (Paris)       Date:  1970-03       Impact factor: 2.607

4.  Studies on adult metachromatic leukodystrophy. 1. Clinical, morphological and histochemical observations in two cases.

Authors:  D Müller; H Pilz; V ter Meulen
Journal:  J Neurol Sci       Date:  1969 Nov-Dec       Impact factor: 3.181

5.  Late adult metachromatic leukodystrophy. Arylsulfatase A activity of leukocytes in two families.

Authors:  H Pilz
Journal:  Arch Neurol       Date:  1972-07

6.  Metachromatic leukodystrophy in the adult. A biochemical study.

Authors:  G Hirose; N H Bass
Journal:  Neurology       Date:  1972-03       Impact factor: 9.910

7.  Adult metachromatic leukodystrophy (sulphatide lipidosis) simulating acute schizophrenia. Report of a case.

Authors:  T A Betts; W T Smith; R E Kelly
Journal:  Neurology       Date:  1968-11       Impact factor: 9.910

8.  Infantile and adult-onset metachromatic leukodystrophy. Biochemical comparisons and predictive diagnosis.

Authors:  A K Percy; M M Kaback
Journal:  N Engl J Med       Date:  1971-09-30       Impact factor: 91.245

9.  The neuropathy of sulfatide lipidosis (metachromatic leukodystrophy).

Authors:  A Yudell; M R Gomez; E H Lambert; M B Dockerty
Journal:  Neurology       Date:  1967-02       Impact factor: 9.910

10.  Metachromatic leukodystrophy (MLD). IX. Qualitative and quantitative differences in urinary arylsulfatase A in different forms of MLD.

Authors:  D Stumpf; J Austin
Journal:  Arch Neurol       Date:  1971-02
View more
  3 in total

Review 1.  Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature.

Authors:  Asif Mahmood; Jay Berry; David A Wenger; Maria Escolar; Magdi Sobeih; Gerald Raymond; Florian S Eichler
Journal:  J Child Neurol       Date:  2009-12-28       Impact factor: 1.987

2.  Adult metachromatic leucodystrophy: an underdiagnosed disease?

Authors:  M Cerizza; R Nemni; F Tamma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

3.  Phenotypic variation between siblings with Metachromatic Leukodystrophy.

Authors:  Saskia Elgün; Jakob Waibel; Christiane Kehrer; Diane van Rappard; Judith Böhringer; Stefanie Beck-Wödl; Jennifer Just; Ludger Schöls; Nicole Wolf; Ingeborg Krägeloh-Mann; Samuel Groeschel
Journal:  Orphanet J Rare Dis       Date:  2019-06-11       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.